Silodosin is an active pharmaceutical ingredient used as an alpha-1 adrenergic receptor antagonist. It is primarily supplied for the symptomatic management of benign prostatic hyperplasia in pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Silodosin?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Desisopropyl butyl torsemide
pharmaceutical raw material
Cromoglicic acid
pharmaceutical raw material
Bictegravir
pharmaceutical raw material
3b-17-Imino-androst-5-en-3-ol Acetate Dimer
pharmaceutical raw material
(R/S)-silodosin
pharmaceutical raw material
The international HS code for Silodosin (CAS 160970-54-7) is 2933.99.
2933.99
2933 99 80
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
1-(3-hydroxypropyl)-5-[(2R)-2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propyl]-2,3-dihydroindole-7-carboxamide
PNCPYILNMDWPEY-QGZVFWFLSA-N
C[C@H](CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F
Sourcing Silodosin?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.